A detailed history of Shelton Capital Management transactions in Moderna, Inc. stock. As of the latest transaction made, Shelton Capital Management holds 57,984 shares of MRNA stock, worth $2.14 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
57,984
Previous 57,084 1.58%
Holding current value
$2.14 Million
Previous $6.78 Million 42.83%
% of portfolio
0.1%
Previous 0.19%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$63.64 - $125.14 $57,276 - $112,626
900 Added 1.58%
57,984 $3.88 Million
Q2 2024

Aug 13, 2024

SELL
$101.21 - $166.61 $689,948 - $1.14 Million
-6,817 Reduced 10.67%
57,084 $6.78 Million
Q1 2024

May 15, 2024

BUY
$85.37 - $115.44 $5.46 Million - $7.38 Million
63,901 New
63,901 $6.81 Million
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $5.92 Million - $7.78 Million
61,422 New
61,422 $6.34 Million
Q2 2023

Aug 10, 2023

BUY
$118.5 - $160.53 $176,091 - $238,547
1,486 Added 3.02%
50,662 $6.16 Million
Q1 2023

May 11, 2023

BUY
$135.66 - $197.02 $2.56 Million - $3.72 Million
18,872 Added 62.28%
49,176 $7.55 Million
Q4 2022

Feb 13, 2023

SELL
$118.38 - $210.04 $7.52 Million - $13.4 Million
-63,562 Reduced 67.72%
30,304 $5.44 Million
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $33,059 - $54,370
-280 Reduced 0.3%
93,866 $11.1 Million
Q2 2022

Aug 11, 2022

SELL
$117.13 - $176.59 $23,426 - $35,318
-200 Reduced 0.21%
94,146 $13.4 Million
Q1 2022

May 12, 2022

SELL
$126.46 - $235.05 $25,292 - $47,010
-200 Reduced 0.21%
94,346 $16.3 Million
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $517,353 - $844,256
2,291 Added 2.48%
94,546 $24 Million
Q3 2021

Nov 15, 2021

SELL
$221.9 - $484.47 $2.94 Million - $6.42 Million
-13,246 Reduced 12.56%
92,255 $35.5 Million
Q2 2021

Aug 12, 2021

BUY
$129.91 - $234.98 $13.7 Million - $24.8 Million
105,501 New
105,501 $24.8 Million
Q1 2021

May 14, 2021

SELL
$109.18 - $185.98 $11.1 Million - $18.8 Million
-101,342 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$65.74 - $169.86 $6,573 - $16,986
-100 Reduced 0.1%
101,342 $10.6 Million
Q3 2020

Nov 09, 2020

BUY
$54.34 - $94.85 $1.87 Million - $3.26 Million
34,342 Added 51.18%
101,442 $7.18 Million
Q2 2020

Aug 12, 2020

BUY
$29.67 - $80.0 $32,637 - $88,000
1,100 Added 1.67%
67,100 $4.31 Million
Q1 2020

May 13, 2020

BUY
$17.78 - $31.58 $622,300 - $1.11 Million
35,000 Added 112.9%
66,000 $1.98 Million
Q4 2019

Feb 11, 2020

BUY
$13.93 - $21.28 $431,830 - $659,680
31,000 New
31,000 $606,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Shelton Capital Management Portfolio

Follow Shelton Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.